# OnCo record nct07232290 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07232290/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07232290", "NCT07232290" ;
  schema:name "Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera"@en ;
  schema:description "A phase 2 trial of Flonoltinib 75mg in myeloproliferative neoplasms, run by Chengdu Zenitar Biomedical Technology Co., Ltd, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07232290/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07232290> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-09-23" ;
  onco:cancers <https://onco.cc/cancers/myeloproliferative-neoplasms/> ;
  onco:drugs <https://onco.cc/drugs/flonoltinib/> ;
  onco:companies <https://onco.cc/companies/chengdu-zenitar-biomedical-technology/> .